| 1. | | Recruiting | Cardiopulmonary Effects of Particulate Exposure
Conditions: Respiratory Tract Diseases; Cardiac Diseases; Bronchitis |
| 2. | | Recruiting | Pirfenidone for the Treatment of Patients with Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF)
Conditions: Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis |
| 3. | | Recruiting | Study of Hepatic Glucose Production and De novo Lipogenesis in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis |
| 4. | | Recruiting | Study of Energy Requirements in Critically Ill Newborns
Condition: Respiratory Distress Syndrome |
| 5. | | Recruiting | Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis
Condition: Cystic Fibrosis |
| 6. | | Recruiting | Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
Condition: Meconium Aspiration |
| 7. | | Recruiting | Phase I Study of Vasoactive Intestinal Peptide in Patients with Acute Respiratory Distress Syndrome and Sepsis
Conditions: Sepsis; Respiratory Distress Syndrome; Respiratory Distress Syndrome, Adult |
| 8. | | Recruiting | Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
Conditions: Osteoporosis; Cystic Fibrosis |
| 9. | | Recruiting | Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
Condition: Cystic Fibrosis |
| 10. | | Recruiting | APC-111 once a day (QD) for 7 days vs. Penicillin taken four times a day (QID) for 10 days in Patients with Strep Throat
Conditions: Pharyngitis; Tonsillitis |
| 11. | | Recruiting | Avastin/Placebo + Tarceva or Taxotere for Second-line Advanced Non-small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Adenocarcinoma; Carcinoma, Large Cell |
| 12. | | Recruiting | Docetaxel or Pemetrexed with or without Cetuximab in Patients with Recurrent or Progressive Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer |
| 13. | | Recruiting | Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Carcinoma, Non-Small-Cell Lung; Lung Cancer |
| 14. | | Recruiting | Study to Evaluate AMG 706 with or without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Subjects with Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung |
| 15. | | Recruiting | Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung |
| 16. | | Not yet recruiting | Complementary and Alternative Medicine Use in Low Income African American and Caucasian Adults with Asthma
Condition: Asthma |
| 17. | | Not yet recruiting | Improving Asthma Care for Minority Children in Head Start
Conditions: Asthma; Lung Diseases |
| 18. | | Recruiting | Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children
Condition: Asthma |
| 19. | | Recruiting | CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor |
| 20. | | Recruiting | Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Conditions: recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 21. | | Recruiting | Docetaxel and Carboplatin With or Without Zoledronate in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung; large cell lung cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ... |
| 22. | | Recruiting | ZD6474, Carboplatin, and Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 23. | | Recruiting | Satraplatin for Locally Advanced Non-Small Cell Lung Cancer with Simultaneous Radiotherapy
Conditions: Carcinoma, Non-Small Cell Lung; Lung Cancer |
| 24. | | Recruiting | An Investigational Intravenous (IV) Administration of an Approved Drug for Acute Asthma
Condition: Asthma |
| 25. | | Recruiting | Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
Conditions: HIV Infections; Influenza |
| 26. | | Recruiting | Genetic and Environmental Pathogenesis of PPH
Conditions: Lung Diseases; Hypertension, Pulmonary |
| 27. | | Recruiting | Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 28. | | Recruiting | Vaccine Therapy and Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery
Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 29. | | Not yet recruiting | Pulmonary Rehabilitation Education With or Without Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemotherapy and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung; Bronchoalveolar Cell Lung Cancer; large cell lung cancer; Non-small cell lung cancer; Pulmonary Complications; ... |
| 30. | | Recruiting | Genetic Risk Factors for Severe Asthma
Condition: Asthma |
| 31. | | Not yet recruiting | Impact of CPAP on Functional Outcomes in Milder Obstructive Sleep Apnea (CATNAP)
Conditions: Lung Diseases; Sleep Apnea Syndromes; Sleep; Hypertension |
| 32. | | Recruiting | A Cancer Vaccine (CG8123) Given with and without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung |
| 33. | | Recruiting | Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer
Condition: stage I non-small cell lung cancer |
| 34. | | Not yet recruiting | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
| 35. | | Recruiting | Celecoxib and Gefitinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 36. | | Recruiting | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
Conditions: Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer |
| 37. | | Recruiting | EPO906 in Patients with Late Stage Non-Small-Cell Lung Cancer (NSCLC)
Conditions: Non-small cell lung cancer; NSCLC |
| 38. | | Recruiting | STA-4783 in Combination with Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients with Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 39. | | Recruiting | Alimta (pemetrexed) plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
Condition: Pleural Neoplasms |
| 40. | | Not yet recruiting | Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ... |
| 41. | | Recruiting | Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer; Adenocarcinoma of the Lung; ... |
| 42. | | Not yet recruiting | Erlotinib in Treating Patients With Early-Stage Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
| 43. | | Recruiting | Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
Condition: Obstructive Sleep Apnea Syndrome |
| 44. | | Recruiting | Safety Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients with Advanced Emphysema
Condition: Pulmonary Emphysema |
| 45. | | Recruiting | Advanced Or Metastatic Non-Small Cell Lung Cancer Study In Patients Who Have Received One Platinum-based Chemotherapy
Condition: Non-small cell lung cancer |
| 46. | | Recruiting | Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; ... |
| 47. | | Not yet recruiting | Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 48. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer |
| 49. | | Recruiting | FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor |
| 50. | | Not yet recruiting | Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
